A Novel Tightly Regulated Gene Expression System for the Human Intestinal Symbiont Bacteroides thetaiotaomicron by Nikki Horn et al.
METHODS
published: 13 July 2016
doi: 10.3389/fmicb.2016.01080
Frontiers in Microbiology | www.frontiersin.org 1 July 2016 | Volume 7 | Article 1080
Edited by:
Christian Sohlenkamp,
Universidad Nacional Autónoma de
México, Mexico
Reviewed by:
Miguel Angel Cevallos,
Universidad Nacional Autónoma de
México, Mexico
C. Jeffrey Smith,
East Carolina University, USA
*Correspondence:
Régis Stentz
regis.stentz@ifr.ac.uk
Specialty section:
This article was submitted to
Microbial Physiology and Metabolism,
a section of the journal
Frontiers in Microbiology
Received: 10 May 2016
Accepted: 27 June 2016
Published: 13 July 2016
Citation:
Horn N, Carvalho AL, Overweg K,
Wegmann U, Carding SR and
Stentz R (2016) A Novel Tightly
Regulated Gene Expression System
for the Human Intestinal Symbiont
Bacteroides thetaiotaomicron.
Front. Microbiol. 7:1080.
doi: 10.3389/fmicb.2016.01080
A Novel Tightly Regulated Gene
Expression System for the Human
Intestinal Symbiont Bacteroides
thetaiotaomicron
Nikki Horn 1, Ana L. Carvalho 1, Karin Overweg 1, Udo Wegmann 1, Simon R. Carding 1, 2 and
Régis Stentz 1*
1Gut Health and Food Safety Programme, Carding’s Lab, Institute of Food Research, Norwich, UK, 2Department of
Medicine, Norwich Medical School, University of East Anglia, Norwich, UK
There is considerable interest in studying the function of Bacteroides species resident
in the human gastrointestinal (GI)-tract and the contribution they make to host health.
Reverse genetics and protein expression techniques, such as those developed for
well-characterized Escherichia coli cannot be applied to Bacteroides species as they
and other members of the Bacteriodetes phylum have unique promoter structures.
The availability of useful Bacteroides-specific genetic tools is therefore limited. Here we
describe the development of an effective mannan-controlled gene expression system
for Bacteroides thetaiotaomicron containing the mannan-inducible promoter–region
of an α-1,2-mannosidase gene (BT_3784), a ribosomal binding site designed to
modulate expression, a multiple cloning site to facilitate the cloning of genes of
interest, and a transcriptional terminator. Using the Lactobacillus pepI as a reporter
gene, mannan induction resulted in an increase of reporter activity in a time- and
concentration-dependent manner with a wide range of activity. The endogenous BtcepA
cephalosporinase gene was used to demonstrate the suitability of this novel expression
system, enabling the isolation of a His-tagged version of BtCepA. We have also shown
with experiments performed in mice that the system can be induced in vivo in the
presence of an exogenous source of mannan. By enabling the controlled expression of
endogenous and exogenous genes in B. thetaiotaomicron this novel inducer-dependent
expression system will aid in defining the physiological role of individual genes and the
functional analyses of their products.
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INTRODUCTION
Inducible expression systems are essential molecular tools designed to perform phenotypic
examinations of deletion mutants complemented for one or several genes of interest with the aim
of defining the role and function of the expressed protein(s). This procedure often requires the use
of finely tuned gene regulation which is particularly critical for the study of genes exhibiting toxic
effects when expressed above normal physiological levels.
There is considerable interest in using dominant members of the human intestinal microbiota
such as B. thetaiotaomicron as a model system to understand and identify the bacterial factors that
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are important for successful colonization of the GI-tract and the
establishment of microbe-host mutualism. B. thetaiotaomicron
has the capacity to utilize a wide variety of otherwise indigestible
dietary plant polysaccharides and host-derived glycans as a
source of carbon and energy (Salyers et al., 1977). The functional
analysis of Bacteroides genes and metabolic pathways is however
constrained by a lack of genetic tools. The genetic tools
developed for model microorganisms such as Escherichia coli are
of very limited use for Bacteroides species that have promoter
structures with a unique consensus sequence (Bayley et al., 2000)
recognized by its core RNA polymerase and its own unusual
primary sigma factor (Vingadassalom et al., 2005). Parker and
Smith circumvented this obstacle by engineering a B. fragilis
promoter to which an E. coli promoter-regulatory region was
added to construct an isopropyl β-D-1-thiogalactopyranoside
(IPTG)-inducible expression system adapted to B. fragilis (Parker
and Jeffrey Smith, 2012). However, the range of activity of this
engineered Bacteroides expression vector is only 7–10-fold, which
is a limiting factor when larger changes of protein expression
are needed. Recently, Mimee et al. (2015) developed this system
further by investigating the positional effects of operator sites
on gene expression. This strategy produced IPTG-inducible
promoters eliciting up to 22-fold changes in gene expression.
The authors expanded further the range of gene expression (up
to 10,000-fold range) using combinations of constitutive
Bacteroides-derived promoters and ribosome binding
sites.
Here we describe the development of an inducible gene
expression system for B. thetaiotaomicron that is based upon
an endogenous mannan-inducible promoter. This system has
proven effective for the controlled expression of the β-lactamase
BtCepA resulting in B. thetaiotaomicron displaying a broad range
of minimum inhibitory concentrations (MIC) of ampicillin in a
dose-dependent manner which correlated with mannan-induced
BtCepA enzyme levels.
MATERIALS AND METHODS
Bacterial Strains, Growth Conditions, and
Media
All E. coli and B. thetaiotaomicron strains used in this study
are listed in Table 1. Bacteroides strains were grown in either
Brain Heart Infusion (BHI) medium (Oxoid/Thermo Fisher,
Basingstoke, UK) supplemented with 0.001% hemin (BHIH)
or in Bacteroides Adapted Defined Medium (BDMA, See Table
S1) adapted from (Martens et al., 2008). Antibiotics were
added as selective agents when appropriate: gentamicin (200
µg/ml), erythromycin and tetracycline (5 µg/ml). Cultures were
incubated under anaerobic conditions at 37◦C. E. coli strain
JM109 was used for routine cloning and DNA manipulations.
Cultures were grown in Luria Bertani (LB) medium at 37◦C.
Ampicillin (200 µg/ml) was added when appropriate. The E. coli
strain J53/R751 was supplemented with 200mg/ml trimethoprim
when grown for 18 h. Plasmids constructed in E. coli were
mobilized into Bacteroides strains by triparental mating using
J53/R751 as the conjugal helper strain (Shoemaker et al., 1986).
Electrocompetent E. coli cells were prepared and transformed by
the method of Sambrook and Russell (2001).
Identification of Inducible Promoters
The Gene Expression Omnibus data repository (NCBI; http://
www.ncbi.nlm.nih.gov/geo/) was consulted in order to identify
genes exhibiting low basal expression in the presence of glucose
but were highly induced in the presence of another carbon-
source in B. thetaiotaomicron VPI-5482. The Series GSE11962
[growth of B. thetaiotaomicron on purified host mucosal glycans
and glycan fragments (Martens et al., 2008)] was used for the
identification of promoters.
Plasmid Constructions
Removal of the P1 Promoter from pGH022
First, a 228-bp fragment was amplified from pGH022 (SeeTable 1
for a list of plasmids) using primer f-noPpepI (See Table S2 for a
list of primers), which contains the restriction sites SphI, NcoI,
XhoI, and Eco47III and incorporates the transcription initiation
site (TIS) and a ribosome binding site for medium level protein
expression (RBSmed; original name RBSxyl−20 in Wegmann et al.,
2013), and primer r-ppepI/NotI, located 157 bp downstream of
the start codon of pepI. This fragment was digested with SphI and
NotI, and cloned into SphI- and NotI-digested pGH022 to create
pGH063.
Insertion of the BT-3784 Promoter (P3784)
The 272-bp region located upstream of gene BT_3784 (putative
alpha-1,2-mannosidase) was amplified from B. thetaiotaomicron
VPI-5482 genomic DNA using primers f-3784_3786 and r-
3784_3786_sp. This fragment was digested with SphI and cloned
into SphI- and Eco47III-digested pGH063 to create pGH066,
thereby inserting the BT-3784 promoter.
Replacing the P1-RBSmed Region of pGH022 with
P3784-RBSlow
To replace the region spanning the P1 promoter to the RBSmed
sequence of pGH022 with the P3784 promoter and a low level
protein expression ribosome binding site equivalent [RBSlow;
original name Shine Delgarno 8 (SD8) in (Wegmann et al.,
2013)], splice overlap extension PCR was employed. To this
end, Amplicon 1 was generated from pGH066 using primers
f-RBSlow-pepI and primer r-3784_3786_sp. Amplicon 2 was
generated from pGH001 using primers r-3784_RBSlow and r-
ppepI/NotI. Using a mixture of amplicon 1 and 2 as a template
and primers r-3784_3786_sp and r-ppepI/NotI, splice PCR was
performed. A 452-bp SphI- and NotI-digested fragment of this
PCR product was then used to replace the corresponding 329-bp
fragment of pGH022 to create pGH105.
Expression Vectors pGH106 and pGH107
To construct the expression vectors pGH106 (medium) and
pGH107 (low) insert sequences were amplified from pGH066
using either primer f-RBSmed_MCS or primer f-RBSlow_MCS,
together with primer r-3784_3786_sp. A 297-bp (RBSmed) or
292-bp (RBSlow) SphI- and NcoI- digested fragment of each PCR
product was used to replace the corresponding 169-bp fragment
of pGH020.
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TABLE 1 | List of bacterial strains and plasmids used in this study.
Species Strain Plasmid Promoter RBS Gene Antibiotic References
overexpressed selection
E. coli JM109 GH019 pGH001 P1 Low pepI Amp Wegmann et al., 2013
GH079 pGH020 P1 Med Amp Wegmann et al., 2013
GH081 pGH022 P1 Med pepI Amp Wegmann et al., 2013
GH188 pGH063 Med pepI Amp/Tet This study
GH303 pGH117 P3784 Med Amp/Ery This study
GH317 pGH122 P3784 Low Amp/Ery This study
GH349 pGH141 P3784 Low Amp/Ery This study
GH350 pGH142 P3784 Med Amp/Ery This study
GH405 pGH125med P3784 Med Amp/Ery This study
B. thetaiotaomicron VPI-5482 DMSZ Collection
GH221a Tet Stentz et al., 2015
GH189 pGH022 P1 Med pepI Tet Wegmann et al., 2013
GH190 pGH063 Med pepI Tet This study
GH193 pGH066 P3784 Med pepI Tet This study
GH287 pGH105 P3784 Low pepI Tet This study
GH288 pGH106 P3784 Med Tet This study
GH289 pGH107 P3784 Low Tet This study
GH359 pGH117 P3784 Med Ery This study
GH360 pGH122 P3784 Low Ery This study
GH361a pGH141 P3784 Low BtcepA Ery This study
GH364a pGH142 P3784 Med BtcepA Ery This study
GH402a pGH150 P3784 Med BtcepA[His]6 Ery This study
aB. thetaiotaomicron 1BtcepA strain.
Amp, ampicillin; Tet, tetracycline; Ery, erythromycin.
Replacing tetQ with ermF
The primer pair ccr_amont2 and ccr_aval2 was used to amplify a
1500-bp region carrying ermF from the plasmid pFD516 (Smith
et al., 1995). The ermF fragment was digested with NdeI and
cloned into NdeI-digested (blunted) and NsiI-digested pGH106
or pGH107 to replace the existing 1839-bp fragment of each,
to create pGH117 (RBSmed) and pGH122 (RBSlow), respectively,
(Figure 1).
Addition of the Tev/6xHis-tag Linker to pGH117
Primers Tev-His6_linker_5′ and Tev-His6_linker_3′ were
annealed to form a 66-bp NcoI-StuI-SmaI linker with NcoI
and SmaI compatible ends enabling the direct cloning of this
fragment into NcoI- and SmaI-digested pGH117, to create
pGH125med (Figure 1). The presence of this linker supplies
the option to clone a gene of interest into the NcoI and StuI
sites of pGH125med, the result of which is the addition of
an epitope recognition site for the TEV protease enzyme
followed by a 6xHis-tag to the C-terminus of the final expressed
protein.
Cloning of Native and Recombinant
BtCepA
The primer pair Lactamase_F and Lactamase_EcoRI_R was used
to amplify an 885-bp region from B. thetaiotaomicron VPI-
5482 genomic DNA encoding BtcepA. The BtcepA fragment was
digested with EcoRI before cloning it into the NcoI-digested
(blunted) and EcoRI-digested pGH122 (RBSlow) or pGH117
(RBSmed) to create pGH141 and pGH142, respectively. In the
case of recombinant BtcepA the primer pair Lactamase_F and B-
Lact_nostop_R was used to amplify an 875-bp region encoding
BtcepA[His]6 from B. thetaiotaomicron VPI-5482 genomic DNA.
The BtcepA[His]6 fragment was cloned into the NcoI-digested
(blunted) and StuI-digested pGH125med (RBSmed[His]6) to
create pGH150.
Enzyme Assays and Protein Determination
The pepI gene of Lactobacillus delbrueckii subsp. lactis encoding
peptidase I and the BtcepA gene encoding a B. thetaiotaomicron
β-lactamase were used as reporters to study promoter activity
in B. thetaiotaomicron in response to the mannan inducing
agent. The B. thetaiotaomicron strains under study were grown
in BDMA. For the PepI assay, cultures (200 ml) were grown
in duplicate to an optical density at 600 nm of 0.5 before
induction. To determine the optimal inducer concentration,
mannan was added to 20 ml aliquots at a final concentration of
0, 0.1, 1.0, 5.0, 10, 50, or 100 mg/L. Following a 2-h induction
period cells were collected by centrifugation at 6000 g for 15
min at 4◦C. The preparation of B. thetaiotaomicron cell-free
extracts was performed as previously described (Wegmann et al.,
2013). To determine the optimal induction time, mannan was
added to a final concentration of 100 mg/l and incubation
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FIGURE 1 | Plasmid map of the inducible expression vectors pGH117, pGH122, and pGH125med. The sequence of the multiple cloning site flanked by the
NcoI and EcoRI restriction sites is shown below for each vector. RBSxyl120 is a ribosome binding site providing medium level protein expression and SD-8 allows low
level expression.
continued. Subsequently, 20 ml samples were collected over
time and the cells harvested as described above. The protein
concentration and peptidase I activity was determined according
to the method described by Wegmann et al. (2013). Specific
activity is expressed as nanomoles of p-nitrophenol released
from the chromogenic substrate per milligram protein per
minute. For the β-lactamase assay, cultures (200 ml) were grown
in duplicate to an optical density at 600 nm of 0.5 before
inducing 20 ml aliquots with varying levels of mannan (See
Table 2) or 5 mg/L of cefotaxime. Periplasmic proteins were
prepared as described by Stentz et al. (2015). β-lactamase activity
was assessed spectrophotometrically by hydrolysis of nitrocefin
according to the manufacturer’s instructions (Calbiochem).
The means and standard deviations presented are based
upon two biological replicates with three technical replicates
each.
Frontiers in Microbiology | www.frontiersin.org 4 July 2016 | Volume 7 | Article 1080
Horn et al. Inducible System in Bacteroides thetaiotaomicron
TABLE 2 | BtCepA β-lactamase activity after mannan induction.
Straina Description Mannan
(mg/l)
nmol/mg Fold-
/min Inductionc
GH359 WT (P3784_low) 0 304.5±41.3 –
0
[Cef5]
b
642.9±70.9 –
GH360 1BtcepA (P3784_low) 50 3.4±2.0 –
GH361 1BtcepA
(P3784_low::BtcepA)
0 11.4±0.3 1.0
50 131.7±4.6 11.6
100 177.1±26.9 15.6
250 191.1±25.5 16.8
GH364 1BtcepA
(P3784_med::BtcepA)
0 1016.9±13.4 89.4
5 5872.3±350.4 516.4
50 13133.2±503.7 1154.9
aThe strains are also described in Table 1.
bAddition of 5 mg/l cefotaxime.
c Induction factor = the mean value obtained in the indicated conditions/the mean value
obtained for the non-induced GH361 strain (11.4).
BtCepA Purification
For the purification of BtCepA[His]6 from B. thetaiotaomicron,
cultures (100 ml) were grown to an optical density at 600 nm of
0.5 before inducing for 2-h with 100 mg/ml of mannan. Cells
were collected in two aliquots of 50 ml by centrifugation at
3500 g for 10 min at ambient temperature. Each 50 ml cell pellet
was processed to extract its periplasmic proteins as described
by Stentz et al. (2015) with the exception that a final volume
of 0.4 ml of ice-cold MgSO4 5 mM solution was used. To the
recovered osmotic shock fluid, 63 ml of 10x concentrated lysis
buffer (NaH2PO4 0.5 M, NaCl 0.3 M, imidazole 0.1 M, pH8) was
added before the final volume was adjusted to 600ml using 5 mM
MgSO4. Contaminating cell debris was removed by centrifuging
at 12,000 g for 15 min at 4◦C before continuing the purification
process using a Ni-NTA spin Kit (Qiagen, UK). Purification of
BtCepA[His]6 was performed under native conditions according
to the manufacturer’s instructions. Selected spots were picked
on the single band obtained after SDS-PAGE and trypsin-
digested using the ProPick Spot Picker (Genomic Solutions) and
ProGest protein digestion robot (Genomic Solutions) prior to
peptide mass fingerprinting on an Ultraflex II MALDI-TOF-TOF
(Bruker) using an oﬄine version of Mascot (Matrix Sciences)
searching against B. thetaiotaomicron sequences.
Animal Experiments
B. thetaiotaomicron was established within the intestine of 7-
week-old male C57BL/6J WT mice housed in a conventional
animal facility after treating for 3 days with 1 mg/ml ampicillin
and 1 mg/ml neomycin administered via drinking water.
Bacterial suspensions of the GH361 strain [1 × 108 colony-
forming units (CFU) in 100µl of phosphate buffered saline] were
administrated by orogastric gavage to a total of eight mice four
of which were given access to drinking water containing 2.5%
(v/v) mannan-oligosaccharide supplement (ActiveMOS, Orffa,
Werkendam, Netherlands) prepared treating the powder (10%
w/v) with 1% NaOH at 100◦C for 1 h, cooling and neutralizing to
pH7 with dilute HCl solution (Huang et al., 2010). We note that
addition of the resulting mannan solution to growth cultures at a
concentration of 2.5% (v/v) fully promoted the mannan-induced
system. After 3 days all mice were injected i.p. with ceftriaxone
(0.4 mg/mice), which was repeated every 2–3 days. Fresh feces
were collected into sterile containers, weighed and homogenized
in PBS. Serial dilutions of the supernatants were plated onto
BHI supplemented with 1.5 µg/ml tetracycline and 5 µg/ml
erythromycin and incubated anaerobically at 37◦C with CFU
counted 48 h later. The study was reviewed and approved by the
Animal Welfare and Ethical Review Body (AWERB, University
of East Anglia, Norwich, UK) and was conducted within the
provisions of the Animals (Scientific Procedures) act 1986. To
confirm that the chow (Rat and Mouse n◦3 breeding, Special
Diet Services) used in this experiment did not contain α-mannan
or derivatives able to stimulating the system, the chow was
subjected to a mannan extraction process performed in alkaline
conditions, as previously described (Huang et al., 2010). The
resulting solution was added at a 1:5 dilution to fresh medium
with no stimulation of the mannan-inducible P3784 promoter
observed after growth of the cells.
RESULTS AND DISCUSSION
Designation of a B. thetaiotaomicron
Inducible Promoter
To develop an inducible gene expression system that can be used
in B. thetaiotaomicron, publicly available microarray data were
examined for inducible genes exhibiting a low basal expression
level, and a high expression level (increased by more than 100-
fold) in the presence of the inducer. Genes repressed by glucose
and induced in the presence of other defined carbon-sources
were identified using the NCBI Gene Expression Omnibus web
tool (http://www.ncbi.nlm.nih.gov/geo/, series GSE11962) and
obtained by transcriptional profiling of B. thetaiotaomicron with
the aim of establishing the mechanisms underlying host glycan
foraging (Martens et al., 2008). Among possible candidates the
BT_3784 gene encoding an α-1,2-mannosidase (Xu et al., 2003),
that is part of the polysaccharide utilization locus (PUL) 68 (4)
later named MAN-PUL2 (Cuskin et al., 2015) and is induced
by the yeast polysaccharide α-mannan, was selected. A 272-
base pair DNA fragment located upstream of the BT_3784 gene
(Presentation 1) was cloned in front of the peptidase I reporter
gene (Klein et al., 1994) in an expression vector created to express
medium levels of protein in Bacteroides species (Wegmann et al.,
2013).The resulting construct hosted by B. thetaiotaomicron
created the strain GH193, which was tested for its capacity to
conditionally express PepI used as a reporter.
Effect of Carbon Source on BT_3784
Promoter Activity
The reporter activity of GH193 was tested after growth in
rich medium (BHIH) and in minimal medium (BDMA)
supplemented with different carbon-sources, in the presence
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or absence of the exogenous mannan (Figure 2). In minimal
media the growth rate of strain GH193 was similar in all cases
independent of the carbon source present with the exception
of mannan for which GH193 exhibited a slower growth with
a generation time of 130 min compared to 90 min under the
other conditions. In rich media, reporter activity in GH193 did
not significantly increase upon mannan induction. As BHI (to
which hemin (H) was added) contains 0.2% glucose, this suggests
that glucose represses the expression of BT_3784 as reported by
Martens et al. (2008), despite the presence of mannan. However,
in minimal medium supplemented with glucose as the major
carbon source mannan induction resulted in an increase of PepI
activity of about 15-fold (Figure 2) indicating that additional
sources of repression are most likely present in BHI mixture.
Mannan-induced PepI activity for cells grown on galactose,
lactose and xylose was increased 110 to 120-fold compared to the
respective control cultures lacking mannan (Figure 2). The PepI
activities measured for cells grown on arabinose and mannose in
the presence of mannan, although lower, were still 87 and 109
times higher, respectively, than control cultures lacking mannan
(Figure 2). Not surprisingly, despite a slower growth rate, cells
grown on mannan exhibited PepI activity comparable to the
activities obtained for mannan-induced cells grown on arabinose
and mannose.
Among the carbon sources tested in this study, only
glucose negatively affected mannan induction of the BT_3784
promoter (P3784). Glucose negatively regulates expression of α 1,2
mannosidase as previously observed in other Bacteroides species
for the expression of other glycosidases such as β-glucosidase in
B. ruminicola (Strobel and Russell, 1987) or xylanase in B. ovatus
(Hamady et al., 2008).
Of note, low levels of PepI activity were detectable in the
absence of mannan consistent with previous data showing
low level of B. thetaiotaomicron PUL expression in conditions
lacking the relevant substrates (Sonnenburg et al., 2006; Martens
FIGURE 2 | Expression of pepI under the control of P3784 in the
presence of different carbon sources. The B. thetaiotaomicron strain
GH193 containing the pepI gene under the dependence of the P3784 promoter
was grown in the BHI complex medium to which hemin was added (BHIH).
BHI is commercially supplied and contains 0.2% glucose. GH193 was also
grown in minimal medium (BDMA) on different carbon sources (0.5%) to which
50 mg/L mannan (extracted from S. cerevisiae) was added where indicated.
et al., 2009; Sonnenburg et al., 2010). Of significance, the
monosaccharide mannose, one of the major end-products of
mannan enzymatic hydrolysis (Düsterhöft et al., 1993), does not
affect expression of the α 1,2 mannosidase gene although this
substrate has been shown to have an inhibitory effect on the
utilization of several hexoses including glucose and pentoses in
B. thetaiotaomicron (Degnan and Macfarlane, 1995).
Effect of Mannan Concentration and
Induction Time on Promoter Activity
The response of P3784 to increasing concentrations of mannan
was tested for cells grown in minimal medium containing
xylose. The strains tested were GH193, containing a Bacteroides
expression vector that contains a translation initiation signal
designed for medium expression (Wegmann et al., 2013)
and GH287, containing a vector designed for low expression
(Wegmann et al., 2013) to ensure that the widest range of
expression levels were covered with the lowest basal activity.
The basal level activity of P3784 measured for GH287 was five-
fold lower than for strain GH193 (Figure 3A). For both strains
GH193 and GH287, PepI activity reached its peak at mannan
concentrations as low as 50 mg/l (Figure 3A).
To further optimize the conditions of induction, the
minimum induction time required to generate the highest level of
FIGURE 3 | Determination of optimal conditions for mannan-induced
gene expression. (A). The B. thetaiotaomicron strain GH193 (light gray)
which expresses medium-levels of PepI under the control of the P3784
promoter was incubated in the presence of increasing concentrations of
mannan and the specific activity of PepI was determined. The GH287 strain
(white) contained a vector designed for low expression levels of PepI. (B).
GH193 was grown in the absence and presence of mannan (100 mg/l) and
PepI activity was measured in protein extracts from samples collected at
different time points post induction.
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reporter activity was determined. The response of the promoter
was assessed over a time-course of mannan-induction in strain
GH193 incubated with 50 mg/L mannan. PepI activity was
detectable after 30 min and continued to increase thereafter with
themaximal activity reached after 90min (Figure 3B). In the case
of GH287, the strain containing the low-RBS-P3784 construct,
maximal activity was also reached after 90min (data not shown).
To facilitate the controlled expression of genes of interest in
Bacteroides, plasmids were constructed that contain a multiple
cloning site in the position of the pepI reporter resulting in
plasmid pGH106 for medium expression and pGH107 for low
expression.
Mannan-Controlled Resistance to
Ampicillin and BtCepA Purification
Since optimization of this novel gene expression system was
based upon the use of a heterologous reporter gene, we chose
to validate the system by determining if it can be used to
study B. thetaiotaomicron genes. For this purpose, we undertook
the complementation of a deletion mutant of BtcepA (Stentz
et al., 2015), a cephalosporinase gene involved in the resistance
of bacterial cells to β-lactam antibiotics. The β-lactamase
activity was measured after 2 h of induction with increasing
concentrations of mannan (Table 2). The activities in the non-
induced and cefotaxime-induced (Stentz et al., 2015) wild-
type strain were also measured and used as references. Use of
increasing concentrations of mannan with the low-expression
system gradually restored up to two-thirds of β-lactamase activity
produced in the wild-type strain. With the medium expression
system graduated and increasing levels of β-lactamase activity
were produced which eventually exceeded the native expression
levels of BtCepA. The use of the low and medium variants
permitted the induction of CepA activity values ranging from 1
to 1155 fold activity values. The basal level measured for the low
expression system was negligible since it represented only 2.7%
of the activity measured for the wild-type control strain.
To establish how these measured activities translate into
resistance to β-lactam antibiotics the MIC of the β-lactam
antibiotic ampicillin was determined for each variant strain
grown in the presence or absence of mannan. The measuredMIC
values closely correlated with β-lactam activities measured in the
corresponding strains (Table 3) with values ranging from 4 to
2048 mg/L.
We also utilized our system for the expression of a
recombinant His-tagged BtCepA protein. To this end, the
C-terminus of the BtcepA coding region was fused to the
hexahistidine affinity tag encoded on pGH125med. The strain
GH402 containing the construct was induced for 5 h in the
presence of mannan and the cell periplasmic fraction was
obtained. Recombinant BtCepA containing a C-terminal His-tag
was purified by affinity chromatography and loaded on a SDS-
PAGE (Figure 4). As a control, native BtCepA was expressed
under the same conditions with a SDS-PAGE-resolved band
corresponding to the protein detected in periplasmic extracts
(Figure 4). A band of a slightly higher molecular weight was
detected for the BtCepA-His6 fusion protein attributable to the
protein tag. After purifying and concentrating the eluted band,
a single species corresponding to BtCepA-His6 was obtained
whereas no comparable band was detected for the empty
vector control with no protein corresponding to BtCepA-His6
detected in the flow-through (Figure 4). Using peptide mass
fingerprinting, the band was identified as BtCepA.
Thus, we have developed an efficient system that allows
phenotypic restoration of B. thetaiotaomicron deletion mutants
in a dose-dependent manner as well as purification of
recombinant proteins produced in their native host, a context
within which recombinant proteins are more likely to retain their
native characteristics.
TABLE 3 | Mannan-induced BtCepA expression increases the resistance of B. thetaiotaomicron to ampicillin.
Strain Mannana Ampicillin (mg/l)b
0 1 2 4 8 16 32 64 128 256 512 1024 2048
WT +
1BtcepA +
1BtcepA (P3784_low) −
1BtcepA (P3784_low) +
1BtcepA (P3784_med) −
1BtcepA (P3784_med) +
aAddition of 100 mg/l mannan to bacterial cultures with an OD600 of 0.5 and the cells were incubated for 16 h.
bDetermination of ampicillin minimum inhibitory concentration (MIC) for the different B. thetaiotaomicron strains. The horizontal bars in black cover the ampicillin concentrations that
permit growth for each of the strains. The results are representative of two independent experiments.
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FIGURE 4 | SDS-PAGE of periplasmic protein extracts before and after
Ni-NTA affinity chromatography. MW, protein ladder; vector, extract from
GH359 strain which contains the empty vector; BtCepA, extract from GH364
which expresses the native BtCepA; BtCepA-His6, extract from GH402 which
expresses the C-terminally His-tagged BtCepA. Flow-through was collected
during the binding step of purification. The arrows indicate the bands
corresponding to the native BtCepA and the higher molecular weight BtCepA
[His]6.
Mannan-Induced BtCepA Expression in the
Mouse Gut
“α-mannan is a fungal cell wall glycan that contains α -
mannosidic linkages similar to those found in the core regions
of N-linked glycans present on secreted mucus and epithelial
surfaces” (Martens et al., 2011). However, expression levels of
the PUL genes involved in mannan utilization in mice fed a diet
lacking exogenous α-mannan were only partial when compared
to other PULs showing high activity in vivo (Martens et al., 2008).
We therefore decided to test the effectiveness of the mannan-
induced system in vivo.
To achieve this, the strain GH361 containing the BtCepA gene
controlled by the inducible low-expression system (Table 1) was
administered by oral gavage to two groups of four mice. Mannan
was given to one of the groups (group A) via the drinking water
and after 2 days both groups of mice were similarly colonized
with GH361 as seen by counting the CFU in fecal samples
(Figure 5) indicating that exposure to mannan did not impact
on the ability of B. thetaiotaomicron to colonize the mouse
intestine. Both groups of mice were challenged every other day
with ceftriaxone (0.4 mg), a third-generation cephalosporin that
is excreted via the biliary route and affects the colonic microbiota
(Arvidsson et al., 1982). The MICs of ceftriaxone determined for
GH361 were 8 mg/l when cells were grown in the absence of
mannan and 64 mg/l when mannan was added to the growth
medium.
Three successive doses of ceftriaxone had no effect on the
levels of GH361 in group A that had been given mannan;
however, the levels of GH361 that had not been given
FIGURE 5 | In vivo induction of ceftriaxone resistance using exogenous
α-mannan. Crosses indicate times of i.p. injections. GA: Group A of mice
received mannan in their drinking water. GB: Group B of mice which were
given access to regular drinking water. CRO: ceftriaxome.
mannan (group B) decreased approximately 15-fold (Figure 5).
Increasing further the amount of ceftriaxone to 0.8mg showed
that both groups were equally affected and population levels
decreased significantly (data not shown). The moderate impact
of mannan observed on GH361 resistance to ceftriaxone is most
likely due to the induction of promoter activity by endogenous
mannan and/or derivatives. The differences obtained in GH361
colonization between the groups with and without added
mannan (p ≤ 0.01) suggests this system could be of use in
in vivo studies. For example, it is conceivable to consider
replacing the mannan promoter with PUL promoters regulated
by plant-derived inducing agents such as arabinogalactan whose
effectiveness was recently demonstrated (Mimee et al., 2015).
CONCLUSION
A novel mannan-inducible gene expression system for use in
B. thetaiotaomicron has been generated. We have shown that
the gene BT_3784 is regulated in response to mannan and have
combined the region located upstream of gene BT_3784 with
two distinct ribosomal binding sites that allow the amount of
gene expression to be tightly regulated. This mannan-controlled
gene expression system is tunable via altering of the mannan
concentrations and, in combination with ribosomal binding sites
RBSmed and RBSlow, generates more than a 1000-fold range of
promoter activity. The system is remarkably efficient as it only
requires concentration of mannan as low as 50 mg/l to be fully
induced. The vectors described in this study constitute together a
valuable tool for expressing Bacteroides genes and purifying their
products, as well as studying Bacteroides cell physiology.
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